Evidence map›Paper›PMID 38509362›Full record

ArticleNature2024

Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis.

Kathryn A Eckartt, Madeleine Delbeau, Vanisha Munsamy-Govender, Michael A DeJesus, Zachary A Azadian, Abhijna K Reddy, Joshua Chandanani, Nicholas C Poulton, Stefany Quiñones-Garcia, Barbara Bosch and 3 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Journal of bacteriology · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kathryn A Eckartt *Laboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Madeleine Delbeau *Laboratory of Molecular Biophysics, The Rockefeller University, New York, NY, USA.
Vanisha Munsamy-GovenderLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Michael A DeJesusLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.ORCID 0000-0003-3867-0299
Zachary A AzadianLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Abhijna K ReddyLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Joshua ChandananiLaboratory of Molecular Biophysics, The Rockefeller University, New York, NY, USA.ORCID 0000-0003-2671-2412
Nicholas C PoultonLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Stefany Quiñones-GarciaLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Barbara BoschLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA.
Robert LandickDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0002-5042-0383
Elizabeth A CampbellLaboratory of Molecular Biophysics, The Rockefeller University, New York, NY, USA. campbee@rockefeller.edu.ORCID 0000-0002-1332-128X
Jeremy M RockLaboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY, USA. rock@rockefeller.edu.ORCID 0000-0002-9310-951X
Rockefeller University · USUniversity of Wisconsin–Madison · US

Funding

Study of M. tuberculosis under human host selection to identify virulence and barrier lipids (Project 1)U19AI162584 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2021 to 2025
$13.5M
STRUCTURE/FUNCTION OF TRANSCRIPTION COMPLEX RNA HAIRPINSR01GM038660 · NIGMS · WASHINGTON UNIVERSITY · PI Robert Landick · 1992 to 2026
$12.2M
Structure/function analyses of essential mycobacterial transcription regulatorsR01GM114450 · NIGMS · ROCKEFELLER UNIVERSITY · PI CAMPBELL, ELIZABETH A · 2015 to 2023
$3.4M
Immunity and Infectious DiseaseT32AI070084 · NIAID · ROCKEFELLER UNIVERSITY · PI Michel C Nussenzweig · 2008 to 2026
$3.3M
Towards a molecular understanding of persistent tuberculosis infectionDP2AI144850 · NIAID · ROCKEFELLER UNIVERSITY · PI ROCK, JEREMY MICHAEL · 2018 to 2018
$2.5M
Genetics and Cell Biology Training ProgramT32GM144299 · NIGMS · ROCKEFELLER UNIVERSITY · PI Viviana I Risca, Tim Stearns · 2022 to 2026
$2.1M
Structural and functional studies of the mycobacterial transcription cycleR35GM151879 · NIGMS · ROCKEFELLER UNIVERSITY · PI ELIZABETH A CAMPBELL · 2024 to 2026
$1.4M
NIAID NIH HHS DP2 AI144850NIAID NIH HHS T32 AI070084NIAID NIH HHS U19 AI162584NIGMS NIH HHS R01 GM038660NIGMS NIH HHS R01 GM114450NIGMS NIH HHS R35 GM151879NIGMS NIH HHS T32 GM144299
6 · The paper itself

Abstract

Drug-resistant bacteria are emerging as a global threat, despite frequently being less fit than their drug-susceptible ancestors

Indexed as

Bacterial ProteinsDrug Resistance, BacterialEvolution, MolecularGenetic FitnessMycobacterium tuberculosisRifampinConserved SequenceDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsGenomicsHumansMutationPeptide Elongation FactorsTranscription FactorsTuberculosis, Multidrug-ResistantBacterial ProteinsDNA-Directed RNA PolymerasesEscherichia coli ProteinsNusG protein, E coliPeptide Elongation FactorsRifampinTranscription Factors

Identifiers

PMID38509362
PMCPMC10990936
OpenAlexW4392984241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.